Literature DB >> 12421953

Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2.

Sandor Cseh1, Loanys Vera, Misao Matsushita, Teizo Fujita, Gérard J Arlaud, Nicole M Thielens.   

Abstract

Ficolins are oligomeric lectins comprising a collagen-like and a fibrinogen-like domain, with a binding specificity for N-acetylglucosamine. It has been reported recently that L-ficolin/P35 associates with mannan-binding lectin (MBL)-associated serine proteases (MASP-1 and -2) and MBL-associated protein 19 (MAp19) in serum and forms complexes able to activate complement. Using surface plasmon resonance spectroscopy we have shown that recombinant MASP-1 and -2, their N-terminal CUB1 (module originally found in complement proteins C1r/C1s, Uegf, and bone morphogenetic protein-1)-epidermal growth factor (EGF)-CUB2 and CUB1-EGF segments, and MAp19 bind to immobilized L-ficolin/P35 in the presence of Ca(2+) ions. Comparable K(d) values were obtained for the full-length proteases and their CUB1-EGF-CUB2 segments (9.2 and 10 nM for MASP-1 and 4.6 and 5.4 nM for MASP-2, respectively), whereas higher values were obtained for the CUB1-EGF segments (26.7, 15.6, and 14.3 nM for MASP-1, MASP-2, and MAp19). These values are in the same range as those determined for the interaction of these proteins with MBL. Binding was Ca(2+) dependent and was only partly sensitive to EDTA for MASP-1, MASP-2, and MASP-2 CUB1-EGF-CUB2. Half-maximal binding was obtained at comparable Ca(2+) concentrations for MASP-1 and MASP-2 (0.45 and 0.47 micro M, respectively), their CUB1-EGF-CUB2 segments (0.37 and 0.72 micro M), and their CUB1-EGF segments (0.31 and 0.79 micro M). These values are lower than those determined in the case of MBL, indicating a difference between MBL and L-ficolin/P35 with respect to the Ca(2+) dependence of their interaction with the MASPs. Preincubation of the MASPs with soluble MBL inhibited subsequent binding to immobilized L-ficolin/P35 and, conversely, suggesting that these lectins compete with each other for binding to the MASPs in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421953     DOI: 10.4049/jimmunol.169.10.5735

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Functional characterization of a ficolin-mediated complement pathway in amphioxus.

Authors:  Huiqing Huang; Shengfeng Huang; Yingcai Yu; Shaochun Yuan; Rui Li; Xin Wang; Hongchen Zhao; Yanhong Yu; Jun Li; Manyi Yang; Liqun Xu; Shangwu Chen; Anlong Xu
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.

Authors:  Nirmal K Banda; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; Stephanie Hyatt; Magdalena Glogowska; Timothy A Wiles; Yuichi Endo; Teizo Fujita; V Michael Holers; William P Arend
Journal:  Mol Immunol       Date:  2011-09-23       Impact factor: 4.407

Review 3.  Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.

Authors:  Rikke Sørensen; Steffen Thiel; Jens C Jensenius
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus.

Authors:  Ian C Michelow; Mingdong Dong; Bruce A Mungall; L Michael Yantosca; Calli Lear; Xin Ji; Marshall Karpel; Christina L Rootes; Matthew Brudner; Gunnar Houen; Damon P Eisen; T Bernard Kinane; Kazue Takahashi; Gregory L Stahl; Gene G Olinger; Gregory T Spear; R Alan B Ezekowitz; Emmett V Schmidt
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

5.  L-ficolin binding and lectin pathway activation by acetylated low-density lipoprotein.

Authors:  J Faro; Y Chen; P Jhaveri; P Oza; G T Spear; T F Lint; H Gewurz
Journal:  Clin Exp Immunol       Date:  2007-11-20       Impact factor: 4.330

6.  Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.

Authors:  Isabelle Bally; Véronique Rossi; Thomas Lunardi; Nicole M Thielens; Christine Gaboriaud; Gérard J Arlaud
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

7.  L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.

Authors:  Youko Aoyagi; Elisabeth E Adderson; Craig E Rubens; John F Bohnsack; Jin G Min; Misao Matsushita; Teizo Fujita; Yoshiyuki Okuwaki; Shinji Takahashi
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

8.  Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1).

Authors:  Mikkel-Ole Skjoedt; Pietro Roversi; Tina Hummelshøj; Yaseelan Palarasah; Anne Rosbjerg; Steven Johnson; Susan M Lea; Peter Garred
Journal:  J Biol Chem       Date:  2012-08-01       Impact factor: 5.157

9.  Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

Authors:  Mohamed R Hamed; Richard J P Brown; Carsten Zothner; Richard A Urbanowicz; Christopher P Mason; Anders Krarup; C Patrick McClure; William L Irving; Jonathan K Ball; Mark Harris; Timothy P Hickling; Alexander W Tarr
Journal:  J Innate Immun       Date:  2014-05-15       Impact factor: 7.349

10.  Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases.

Authors:  Monique Lacroix; Agnès Tessier; Chantal Dumestre-Pérard; Sandrine Vadon-Le Goff; Evelyne Gout; Leena Bruckner-Tuderman; Dimitra Kiritsi; Alexander Nyström; Sylvie Ricard-Blum; Catherine Moali; David J S Hulmes; Nicole M Thielens
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.